Literature DB >> 6273425

Requirements for cholera toxin-dependent ADP-ribosylation of the purified regulatory component of adenylate cyclase.

L S Schleifer, R A Kahn, E Hanski, J K Northup, P C Sternweis, A G Gilman.   

Abstract

The requirements for cholera toxin-catalyzed ADP ribosylation of the purified regulatory component of adenylate cyclase are described. In addition to the toxin, this reaction is dependent on or is facilitated by NAD, GTP, phospholipid, and a factor found associated with plasma membranes from several sources. Factor activity is heat-labile and protease-sensitive but is unaffected by treatment with N-ethylmaleimide. Gel filtration indicates that the factor behaves as a monodisperse species with a Stokes radius of 3.2 nm. The factor thus appears to be a protein that is distinct from any of the known components of adenylate cyclase. Factor activity was also detected in the cytoplasm of S49 cells. The cytoplasmic factor was smaller (Stokes radius = 2.0 nm) than the membrane-derived factor, and it was inactivated in the presence of sodium cholate. The initial rate of activation of the regulatory component of adenylate cyclase by toxin was found to be linearly related to the amount of factor present in the reaction. This has allowed the quantitation and partial purification (33-fold from detergent extracts) of the factor from turkey erythrocyte membranes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6273425

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  ADP-ribosylation factor is functionally and physically associated with the Golgi complex.

Authors:  T Stearns; M C Willingham; D Botstein; R A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  Enhancement of choleragen ADP-ribosyltransferase activities by guanyl nucleotides and a 19-kDa membrane protein.

Authors:  S C Tsai; M Noda; R Adamik; J Moss; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Resolution of two ADP-ribosylation factor 1 GTPase-activating proteins from rat liver.

Authors:  P A Randazzo
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

4.  Multiple roles of Arf1 GTPase in the yeast exocytic and endocytic pathways.

Authors:  N Yahara; T Ueda; K Sato; A Nakano
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

5.  Treatment of human platelets with trypsin, thrombin, or collagen inhibits the pertussis toxin-induced ADP-ribosylation of a 41-kDa protein.

Authors:  E G Lapetina; B Reep; K J Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  Antibody specific to the alpha subunit of the guanine nucleotide-binding regulatory protein Go: developmental appearance and immunocytochemical localization in brain.

Authors:  K J Chang; W Pugh; S G Blanchard; J McDermed; J P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

7.  Interspecies relationships among ADP-ribosylation factors (ARFs): evidence of evolutionary pressure to maintain individual identities.

Authors:  S R Price; M S Nightingale; M Tsuchiya; J Moss; M Vaughan
Journal:  Mol Cell Biochem       Date:  1996-06-07       Impact factor: 3.396

8.  Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.

Authors:  R R Dighe; F J Rojas; L Birnbaumer; A J Garber
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Cloning and expression analysis of an ADP-ribosylation factor from Solanum tuberosum L.

Authors:  J Szopa; B Müller-Röber
Journal:  Plant Cell Rep       Date:  1994-12       Impact factor: 4.570

10.  Guanine nucleotide-binding proteins that enhance choleragen ADP-ribosyltransferase activity: nucleotide and deduced amino acid sequence of an ADP-ribosylation factor cDNA.

Authors:  S R Price; M Nightingale; S C Tsai; K C Williamson; R Adamik; H C Chen; J Moss; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.